Skip to main content

Animations

MJFF Publications

2611 - 2620 of 6568 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2022
  • 2020
  • 2021
  • 2022
  • 2020
  • 2013
  • 2020
  • 2016
  • Summary Details
    OPEN
    Title: Progressive Supranuclear Palsy and Statin Use
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28038
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Usability of the Experience Sampling Method in Parkinson's Disease on a Group and Individual Level
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28028
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.017
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.030
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Altered network stability in progressive supranuclear palsy
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.07.007
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Editorial: Non-neuronal cell heterogeneity in the nervous system during health and disease
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2022.1047296
    Citation Count: 1
  • Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease
    2020
    Summary Details
    OPEN
    Title: Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2019-321759
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates
    Journal Name: Neurological Research
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1179/1743132813y.0000000305
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aax0091
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Deep brain stimulation for levodopa-refractory benign tremulous parkinsonism
    Journal Name: Neurologia i Neurochirurgia Polska
    Publisher: VM Media SP. zo.o VM Group SK
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.pjnns.2016.05.008
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.